Detalhe da pesquisa
1.
Epigenetic regulation during cancer transitions across 11 tumour types.
Nature
; 623(7986): 432-441, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914932
2.
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.
Cancer Res
; 83(8): 1214-1233, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779841
3.
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Nat Commun
; 14(1): 1681, 2023 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973268
4.
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
bioRxiv
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961519
5.
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.
Cancer Res
; 83(24): 4161-4178, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098449
6.
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.
Nat Genet
; 54(9): 1390-1405, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995947
7.
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Nat Commun
; 14(1): 2817, 2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37198186